Innovative drug concept stocks rebounded in the afternoon, with Nanjing New Pharmaceutical hitting the 20cm daily limit.

Innovative drug concept stocks rebounded in the afternoon, with Nanshin Pharmaceutical hitting the 20cm limit-up, Kap Biological rising more than 10%, and Watson Biotech, Shanghai Yizhong, Junshi Biosciences, Wintac Biotech, Vantabio, and Huahai Pharmaceutical following higher. Regarding related ETFs, the GF Innovative Drug ETF (515120) recorded trading volume of 269 million yuan.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin